The Adverse Reactions of Erythropoietin in Methanol Toxicity: A Descriptive Study
International Journal of Medical Toxicology and Forensic Medicine,
Vol. 14 No. 1 (2024),
4 February 2024
https://doi.org/10.32598/ijmtfm.v14i1.43078
Abstract
Background: Nowadays, erythropoietin is employed as a substitute therapy for eye ailments, particularly optic nerve damage induced by methanol toxicity. Despite its benefits, erythropoietin can have negative effects on blood factors. These effects may include thrombosis, stroke, seizures, and changes in hematological function. This study examined the adverse effects of erythropoietin on individuals suffering from optic neuropathy caused by methanol.
Methods: This study was a prospective descriptive study at Loghman Hakim Hospital, Tehran City, Iran, in 2022. The study involved individuals who suffered from methanol poisoning and were administered erythropoietin twice a day for three days, with a dosage of 10000 units each time. Patients were examined up to 6 weeks after discharge in terms of increased hemoglobin levels, seizures, central vascular thrombosis, and heart attack or stroke. The data was analyzed by SPSS software, version 18.
Results: The study comprised of 37 patients. No patient reported seizures, heart and cerebral strokes, and deep vein thrombosis except polycythemia. After being discharged from the hospital, the mean hemoglobin levels increased by 2.01% six weeks later compared to the levels measured during admission. Moreover, there was a 2.4% rise in hemoglobin levels six weeks after discharge when compared to the levels measured two weeks after being discharged.
Conclusion: Using erythropoietin to treat optic neuropathy can improve vision, but it also carries the risk of increasing hemoglobin levels, which must be monitored closely in treated patients.
- Erythropoietin
- Hemoglobin
- Methanol poisoning
- Optic neuropathy
- Side effects
How to Cite
References
Liberski S, Kaluzny BJ, Kocięcki J. Methanol-induced optic neuropathy: A still-present problem. Archives of Toxicology. 2022:1-21.
Pressman P, Clemens R, Sahu S, Hayes AW. A review of methanol poisoning: a crisis beyond ocular toxicology. Cutaneous and ocular toxicology. 2020;39(3):173-9.
Akhgari M, Panahianpour MH, Bazmi E, Etemadi-Aleagha A, Mahdavi A, Nazari SH. Fatal methanol poisoning: features of liver histopathology. Toxicology and industrial health. 2013;29(2):136-41.
Fu J, Jiao J, Weng K, Yu D, Li R. Zebrafish methanol exposure causes patterning defects and suppressive cell proliferation in retina. American Journal of Translational Research. 2017;9(6):2975.
Grzybowski A, Zülsdorff M, Wilhelm H, Tonagel F. Toxic optic neuropathies: an updated review. Acta ophthalmologica. 2015;93(5):402-10.
Klein KA, Warren AK, Baumal CR, Hedges TR. Optical coherence tomography findings in methanol toxicity. International Journal of Retina and Vitreous. 2017;3(1):1-6.
BENNETT Jr IL, CARY FH, MITCHELL Jr GL, COOPER MN. Acute methyl alcohol poisoning: a review based on experiences in an outbreak of 323 cases. Medicine. 1953;32(4):431-63.
Tanrivermis Sayit A, Aslan K, Elmali M, Gungor I. Methanol-induced toxic optic neuropathy with diffusion weighted MRI findings. Cutaneous and Ocular Toxicology. 2016;35(4):337-40.
Sharma R, Marasini S, Sharma AK, Shrestha JK, Nepal BP. Methanol poisoning: ocular and neurological manifestations. Optometry and vision science. 2012;89(2):178-82.
Pakravan M, Esfandiari H, Sanjari N, Ghahari E. Erythropoietin as an adjunctive treatment for methanol-induced toxic optic neuropathy. The American Journal of Drug and Alcohol Abuse. 2016;42(6):633-9.
Feizi S, Alemzadeh-Ansari M, Karimian F, Esfandiari H. Use of erythropoietin in ophthalmology: A review. Survey of Ophthalmology. 2022;67(2):427-39.
Patel S, Rowe MJ, Winters SA, Ohls RK. Elevated erythropoietin mRNA and protein concentrations in the developing human eye. Pediatric research. 2008;63(4):394-7.
Rex TS, Allocca M, Domenici L, Surace EM, Maguire AM, Lyubarsky A, et al. Systemic but not intraocular Epo gene transfer protects the retina from light-and genetic-induced degeneration. Molecular Therapy. 2004;10(5):855-61.
Chung H, Lee H, Lamoke F, Hrushesky WJ, Wood PA, Jahng WJ. Neuroprotective role of erythropoietin by antiapoptosis in the retina. Journal of Neuroscience Research. 2009;87(10):2365-74.
Gong Y, Qiu Y, Song Z, Gu Q, Wu X, Sun X. Effects of single intravitreal rhEPO injection on light-induced retinal injury in rats. Current Eye Research. 2011;36(8):739-46.
Pakravan M, Sanjari N. Erythropoietin treatment for methanol optic neuropathy. Journal of Neuro-Ophthalmology. 2012;32(4):325-8.
Pakdel F, Sanjari MS, Naderi A, Pirmarzdashti N, Haghighi A, Kashkouli MB. Erythropoietin in treatment of methanol optic neuropathy. Journal of Neuro-Ophthalmology. 2018;38(2):167-71.
Zamani N, Hassanian-Moghaddam H, Shojaei M, Rahimian S. Evaluation of the effect of erythropoietin+ corticosteroid versus corticosteroid alone in methanol-induced optic nerve neuropathy. Cutaneous and Ocular Toxicology. 2018;37(2):186-90.
Nekoueifard S, Majidi M. Subcutaneous Erythropoietin Reverses Optic Neuropathy Induced by Methanol Poisoning: Three Case Reports. Iranian Journal of Toxicology. 2020;14(3):187-92.
Vafapour F, Jahangiri-Mehr S, Hassanzadeh S. Delayed reversal of methanol-induced blindness in an adult by a combination of erythropoietin and a high dose of methylprednisolone: a case report. Journal of Medical Case Reports. 2023;17(1):181.
Tabatabaei SA, Amini M, Haydar AA, Soleimani M, Cheraqpour K, Shahriari M, et al. Outbreak of methanol-induced optic neuropathy in early COVID-19 era; effectiveness of erythropoietin and methylprednisolone therapy. World Journal of Clinical Cases. 2023;11(15):3502-10.
Ehrenreich H, Hinze-Selch D, Stawicki S, Aust C, Knolle-Veentjer S, Wilms S, et al. Improvement of cognitive functions in chronic schizophrenic patients by recombinant human erythropoietin. Molecular psychiatry. 2007;12(2):206-20.
Borhani-Haghighi A, Ghodsi M, Razeghinejad MR, Mardani S, Mardani M, Nikseresht AR, et al. Erythropoietin for acute multiple sclerosis in patients with optic neuritis as a first demyelination event. Neurosciences Journal. 2012;17(2):151-5.
Kashkouli MB, Pakdel F, Sanjari MS, Haghighi A, Nojomi M, Homaee MH, et al. Erythropoietin: a novel treatment for traumatic optic neuropathy—a pilot study. Graefe's Archive for Clinical and Experimental Ophthalmology. 2011;249:731-6.
Sühs KW, Hein K, Sättler MB, Görlitz A, Ciupka C, Scholz K, et al. A randomized, double‐blind, phase 2 study of erythropoietin in optic neuritis. Annals of neurology. 2012;72(2):199-210.
İşcan Y, Coşkun Ç, Öner V, Türkçü FM, Taş M, Alakuş MF. Bilateral total optic atrophy due to transdermal methanol intoxication. Middle East African Journal of Ophthalmology. 2013;20(1):92.
Beccari M. Erythropoietin-induced epilepsy in hemodialysis patients? Nephron. 1998;78(3):354-.
Samtleben W, Baldamus C, Bommer J, Grützmacher P, Nonnast-Daniel B, Scigalla P, et al. Indications and contraindications for recombinant human erythropoietin treatment. Erythropoietin: from molecular structure to clinical application. 76: Karger Publishers; 1990. p. 193-200.
Berglund B, Ekblom B. Effect of recombinant human erythropoietin treatment on blood pressure and some haematological parameters in healthy men. Journal of internal medicine. 1991;229(2):125-30.
- Abstract Viewed: 431 times
- pdf Downloaded: 458 times